Chronic mucocutaneous candidosis and other superficial and systemic mycoses successfully treated with ketoconazole.

No abstract is available for this paper.

• Publication year

  1980

• Venue

  Reviews of Infectious Diseases

• Publication date

  1980-07-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1093/CLINIDS/2.4.606PMID 6255540
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Promotion of pseudomycelium formation of Candida albicans in culture: a morphological study of the effects of miconazole and ketoconazole.

  1979cited by this paper
• Ketoconazole, an oral antifungal: laboratory and clinical assessment of imidazole drugs.

  1979cited by this paper
• In vitro synergy and antagonism of antifungal agents against yeast-like fungi.

  1979cited by this paper
• Specific inhibition of in vitro Candida-induced lymphocyte proliferation by polysaccharidic antigens present in the serum of patients with chronic mucocutaneous candidiasis.

  1978influential reference
• Magnetie solid phase enzyme-immunoassay.

  1977cited by this paper
• Basophilic leukocytes in delayed hypersensitivity reactions.

  1974cited by this paper
• Chronic mucocutaneous candidiasis: model-building in cellular immunity.

  1971cited by this paper
• CELLULAR EVOLUTION IN THE SKIN‐WINDOW TEST WITH A SPECIFIC ANTIGEN

  1970cited by this paper
• [The carpet technic, a simple method for taking samples from superficial mycosis].

  1967cited by this paper

• A comprehensive review on azoles based organic wood preservatives and their future prospects

  2025cites this paper
• Emergence of Antifungal Azole Resistance in the Fungal Strains of Tinea corporis, Tinea capitis, Tinea cruris and Tinea pedis from the Locality of Southern Punjab, Pakistan

  2021cites this paper
• Metagenomic Next-generation Sequencing Identified Histoplasma Capsulatum in Lung and Epiglottis of a Chinese Patient: A Case Report.

  2020cites this paper
• History of the development of antifungal azoles: A review on structures, SAR, and mechanism of action.

  2020cites this paper
• Novel insights into P450 BM3 interactions with FDA-approved antifungal azole drugs

  2019cites this paper
• Azole antifungals: 35 years of invasive fungal infection management

  2015cites this paper
• Zygomycoses (II). Entomophthoromycoses tropicales : basidiobolomycose et conidiobolomycose

  2014cites this paper
• Ketoconazole: A Review of its Therapeutic Efficacy in Superficial and Systemic Fungal Infections

  2012influential citation
• Commentary 1

  2012cites this paper
• Historical Introduction: Evolution of Knowledge of the Fungi and Mycoses from Hippocrates to the Twenty‐First Century

  2010cites this paper
• A homozygous CARD9 mutation in a family with susceptibility to fungal infections.

  2009cites this paper
• Spore persistence and likelihood of aeroallergenicity of entomopathogenic fungi used for mosquito control.

  2009cites this paper
• Laryngeal candidiasis in the outpatient setting.

  2009cites this paper
• Zygomycoses (II). Entomophthoromycoses tropicales : basidiobolomycose et conidiobolomycose

  2008cites this paper
• Trichophyton Fungal Keratitis

  2006cites this paper
• Novel ketoconazole analogues based on the replacement of 2,4-dichlorophenyl group with 1,4-benzothiazine moiety: design, synthesis, and microbiological evaluation.

  2006cites this paper
• Immunology of Cutaneous Candidiasis

  2005cites this paper
• History of the development of azole derivatives.

  2004cites this paper
• Determination of ketoconazole in human plasma by high-performance liquid chromatography-tandem mass spectrometry.

  2002cites this paper
• Zygomycoses (II): entomophthoromycoses

  1999cites this paper
• Hamycin treatment of candidiasis in normal and diabetic rats.

  1999cites this paper
• Antifungal agents. Part II. The azoles.

  1999cites this paper
• THIS ARTICLE HAS BEEN RETRACTED Hamycin treatment of candidiasis in normal and diabetic rats

  1999cites this paper
• Clinical pharmacology of systemic antifungal agents: a comprehensive review of agents in clinical use, current investigational compounds, and putative targets for antifungal drug development.

  1998cites this paper
• Cutaneous defenses against dermatophytes and yeasts

  1995cites this paper
• Antifungal agents: an overview. Part I.

  1994cites this paper
• Antifungal agents: an overview. Part II.

  1994cites this paper
• Chronic Mucocutaneous Candidiasis

  1993cites this paper
• Histoplasmosis of the larynx.

  1993cites this paper
• [Autoimmune polyendocrinopathy and chronic mucocutaneous candidiasis].

  1989cites this paper
• Body fluid and endometrial concentrations of ketoconazole in mares after intravenous injection or repeated gavage.

  1989cites this paper
• Treating tinea capitis: should ketoconazole replace griseofulvin?

  1988cites this paper
• [Experience with nizoral treatment of patients with rubromycosis].

  1988cites this paper
• Overview of Fungal Antigens

  1988cites this paper
• Antifungal agents used for deep-seated mycotic infections.

  1987cites this paper
• Chemotherapy of the Systemic Mycoses

  1987cites this paper
• Epidemiology and treatment of tinea capitis: ketoconazole vs. griseofulvin

  1987cites this paper
• Antifungal agents used for deep-seated mycotic infections.

  1987cites this paper
• TREATMENT OF PSEUDALLESCHERIA BOYDII INFECTION WITH ORAL KETOCONAZOLE AND TOPICAL MICONAZOLE

  1987cites this paper
• Pseudoallescheria boydii soft tissue abscess.

  1987cites this paper
• Evolution of antifungal agents: past, present, and future.

  1987cites this paper
• [Nizoral. The outlook for its use and side effects].

  1987cites this paper
• Immunological studies in chronic mucocutaneous candidiasis before and after ketoconazole treatment.

  1987cites this paper
• Microtiter broth dilution method for yeast susceptibility testing with validation by clinical outcome

  1986cites this paper
• Refractory esophageal candidiasis associated with a low molecular weight plasma inhibitor of T-lymphocyte function.

  1986cites this paper
• Microtiter BrothDilution MethodforYeastSusceptibility Testing withValidation byClinical Outcome

  1986cites this paper
• Therapeutic experience with ketoconazole.

  1986cites this paper
• Ketoconazole hepatotoxicity: an in vitro model.

  1986cites this paper
• A case of fungating skin tumors in a young man. North American blastomycosis.

  1986cites this paper
• Ketoconazole therapy for endemic blastomycosis.

  1985cites this paper
• [North American blastomycosis in an African patient--clinical aspects, therapy, immunologic parameters].

  1985cites this paper
• Polyglandular autoimmune syndromes.

  1985cites this paper
• Prévention des mycoses systémiques chez le patient immunodéprimé. A propos d'une étude faite dans les greffes de moelle osseuse allogénique

  1985cites this paper
• Nordamerikanische Blastomykose bei einem Afrikaner ‐Klinik, Therapie, Immunparameter: North American Blastomycosis in an African Patient ‐Clinical Picture, Treatment, Immunological Parameters

  1985cites this paper
• Brain abscesses due to Pseudallescheria boydii associated with primary non-Hodgkin's lymphoma of the central nervous system: a case report and literature review.

  1985cites this paper
• Ketoconazole; Mechanism of Action, Spectrum of Activity, Pharmacokinetics, Drug Interactions, Adverse Reactions and Therapeutic Use

  1984cites this paper
• Present status of the management of patients with defective phagocyte function.

  1984cites this paper
• Clinical Studies on Ketoconazole

  1984cites this paper
• Pharmacokinetics of ketoconazole and treatment evaluation in candidal infections.

  1984cites this paper
• Candida endocrinopathy syndrome

  1984cites this paper
• Ketoconazole. Mechanism of action, spectrum of activity, pharmacokinetics, drug interactions, adverse reactions and therapeutic use.

  1984cites this paper
• Comparison of the therapeutic effect of ketoconazole tablets and econazole lotion in the treatment of chronic paronychia

  1984cites this paper
• Mucormycose naso-orbito-cérébrale traitée par amphotéricine B puis kétoconazole

  1984cites this paper
• Ketoconazole: spectre, pharmacocinétique, tolérance et activité thérapeutique dans les mycoses profondes

  1984cites this paper
• Treatment of Superficial and Deep‐seated Mycoses with Oral Ketoconazole

  1984cites this paper
• Systemic blastomycosis treated with ketoconazole.

  1984cites this paper
• [Monilial granuloma treated successfully with ketoconazole over a period of 30 months].

  1984cites this paper
• Cutaneous lymphatic sporotrichosis treated with ketoconazole—report of an infection acquired in the United Kingdom

  1984cites this paper
• Evaluation of auto-antibodies in chronic mucocutaneous candidiasis without endocrinopathy

  1984cites this paper
• Histopathology of experimental systemic candidosis in guinea-pigs.

  1984cites this paper
• Ketoconazole: An Orally Effective Antifungal Agent Mechanism of Action, Pharmacology, Clinical Efficacy and Adverse Effects

  1984cites this paper
• Immunological observations before and after successful treatment of chronic mucocutaneous candidiasis with ketoconazole and transfer factor

  1984cites this paper
• Clinical Pharmacokinetics of Systemic Antifungal Drugs

  1983cites this paper
• Laboratory and clinical assessment of ketoconazole in deep-seated mycoses.

  1983cites this paper
• A therapeutic update of superficial skin infections.

  1983cites this paper
• Severe chronic mucocutaneous candidiasis

  1983cites this paper
• [Fungal osteoarthritis of the knee with joint destruction treated with ketoconazole].

  1983cites this paper
• In vitro effect of ketoconazole on human neutrophil chemotaxis and Candida albicans killing.

  1983cites this paper
• Ketoconazole (Nizoral, Janssen Pharmaceutica, Inc.)

  1983cites this paper
• Treatment of African histoplasmosis with ketoconazole.

  1983cites this paper
• Quantitation of ketoconazole in biological fluids using high-performance liquid chromatography.

  1983cites this paper
• Ketoconazole.

  1983cites this paper
• Afrikanische Histoplasmose Immunparameter und Behandlung mit Ketoconazol: African Histoplasmosis Immunological Parameters and Treatment with Ketoconazole

  1982cites this paper
• Maxillary sinusitis: isolation of Scedosporium (Monosporium) apiospermum, anamorph of Petriellidium (Allescheria) boydii.

  1982cites this paper
• Candidiasis in captive cetaceans.

  1982cites this paper
• Klinik, Diagnostik mid Therapie der Chromomykose

  1982cites this paper
• Superficial Mycoses: Ketoconazole Treatment Oberflächliche Mykosen: Ketoconazol‐Behandlung

  1982cites this paper
• Intermittent ketoconazole therapy of chronic mucocutaneous candidiasis in childhood

  1982cites this paper
• Ketoconazole in the treatment of chronic mucocutaneous candidiasis secondary to autoimmune polyendocrinopathy-candidiasis syndrome.

  1982cites this paper
• Experiences, Recognitions and Questions in Azole Antimycotics

  1982cites this paper
• [First human case of Drechslera longirostrata mycosis. Spondylodiscitis complicating prosthesis endocarditis. Treatment with combined ketoconazole and amphotericin B].

  1982cites this paper
• Effect of ketoconazole on isolated mitochondria from Candida albicans

  1982cites this paper
• Antifungals today.

  1982cites this paper
• The pharmacokinetics of ketoconazole in severely immunocompromised patients.

  1982cites this paper
• Cellular inflammatory response to fungal antigen studied with the skin window technique-correlation of the exudate with the evolution of the mycotic infection

  1981cites this paper
• A Case of Chronic Mucocutaneous Candidiasis Successfully Treated with Ketoconazole

  1981cites this paper
• [Cutaneous blastomycosis and its treatment. Apropos of a new Moroccan case].

  1981cites this paper
• Progressive disseminated histoplasmosis; favorable response to ketoconazole.

  1981cites this paper